Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists
Background The coronavirus disease 2019 (COVID-19) pandemic has overwhelmed the health systems worldwide. Data regarding the impact of COVID-19 on cancer patients (CPs) undergoing or candidate for immune checkpoint inhibitors (ICIs) are lacking. We depicted the practice and adaptations in the manage...
        Saved in:
      
    
          | Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | BMJ Publishing Group
    
        2020-10-01 | 
| Series: | Journal for ImmunoTherapy of Cancer | 
| Online Access: | https://jitc.bmj.com/content/8/2/e001154.full | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
 
       